CHRS DCF Valuation - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.63 USD -4.4% Market Closed

Market Cap: $244.3m

	Coherus BioSciences Inc NASDAQ:CHRS	US
S	Sabina PCL SET:SABINA	TH
	Elis SA PAR:ELIS	FR
	Global UAV Technologies Ltd OTC:YRLLF	CA
	Avnet Inc NASDAQ:AVT	US
	LG Chem Ltd KRX:051910	KR
	SoftBank Group Corp TSE:9984	JP
	Pixelworks Inc NASDAQ:PXLW	US
	Swiss Prime Site AG SIX:SPSN	CH
	Under Armour Inc NYSE:UAA	US
I	Intact Financial Corp OTC:IFCZF	CA
	MTR Corp Ltd HKEX:66	HK
	HSBC Holdings PLC LSE:HSBA	UK
S	Severn Trent PLC DUS:SVT1	UK
	Hecla Mining Co NYSE:HL	US
	Credit Agricole SA PAR:ACA	FR
	Anywhere Real Estate Inc NYSE:HOUS	US
	Mirion Technologies Inc NYSE:MIR	US
	Sichuan Changhong Electric Co Ltd SSE:600839	CN
	Vericel Corp NASDAQ:VCEL	US
	NOW Inc NYSE:DNOW	US
	Hawaiian Electric Industries Inc NYSE:HE	US
D	Dis-Chem Pharmacies Ltd JSE:DCP	ZA
	Sea Ltd NYSE:SE	SG

CHRS's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.